Innate Pharma
Innate Pharma is a French biotechnology company specializing in cancer immunotherapy.
Price history of Innate Pharma
Price history of Innate Pharma
Performance & Momentum
Strategic Analysis
Innate Pharma • 2026
Innate Pharma positions itself as a specialist in oncology immunotherapy, aiming to develop innovative treatments that target the immune system to fight cancer. Its value is based on its biotechnology expertise and strategic partnerships to advance its drug candidates in R&D.
- Recognized expertise in immunotherapy, a fast-growing segment in oncology
- Pipeline focused on innovative immune-activation mechanisms
- Strong research base supported by international pharmaceutical collaborations
- Recurring financial losses weighing on short-term profitability
- Sharp decline in stock performance over several years, reflecting operational or regulatory challenges
Current momentum is weak and negative, reflecting a difficult period marked by pressure on the stock linked to the slow progress of clinical programs. Investor attention remains focused on the ability to demonstrate significant pipeline progress in order to reverse this trend.
Similar stocks to Innate Pharma
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
